Erratum to: Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
© Simon et al. 2016
Received: 5 April 2016
Accepted: 6 April 2016
Published: 4 May 2016
The original article was published in Arthritis Research & Therapy 2015 17:212
It has come to our attention that, in our recently published article on the incidence of malignancy in adult patients with rheumatoid arthritis , the risk of melanoma requires additional clarification. Indeed, the meta-analysis of the risk of melanoma among patients with rheumatoid arthritis compared with the general population showed a standardized incidence rate ratio of 1.23 (95 % confidence interval 1.01, 1.49). This finding was erroneously included in the list of malignancies for which there was no consistent trend in risk among patients with rheumatoid arthritis versus the general population. Instead, with our current, updated meta-analysis it should be considered that there is now a suggestion of a possible increased risk for melanoma. With respect to the Discussion section of our article, we would like to note that the summary standardized incidence ratio shows a modest increased risk for melanoma.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.